Pediatric Cardiology: The LEAD Initiative — Universal Cholesterol Screening in Children Can Save Lives
Pediatric Cardiology: The LEAD Initiative — Universal Cholesterol Screening in Children Can Save Lives
Source: Journal of Pediatrics, published online September 17, 2025 – LEAD Pediatric Initiative (FH Screening).
Keynotes:
1-Background
• A new multidisciplinary panel released updated recommendations to help doctors screen more children for familial hypercholesterolemia (FH) — a genetic disorder that causes high cholesterol from birth.
2-About FH
• FH is a hereditary condition that leads to very high LDLsuggestive of FH: ≥190 mg/dL(or ≥400–500 mg/dL Severe FH (Homozygous form).
• If not detected or treated early, it can cause premature heart attacks or serious heart disease in youth and young adults.
• Early detection allows lifelong prevention and treatment that can save lives.
3-Guidelines: Universal lipid screening for ages 9–11 recommended since 2011.
• Gap: Only ≈11% of U.S. children screened.
• Screening based only on symptoms and family history — misses 30–60% of children who actually have lipid disorders
4-The LEAD Pediatric Initiative (2024–2025)
• The Family Heart Foundation launched the LEAD Initiative (Leveraging Evidence and Data) to close the gap in pediatric screening.
• It engages clinicians, researchers, and families to identify barriers and provide evidence-based solutions for nationwide screening.
• Partnerships were formed to educate families, support policy updates, and improve care for affected children.
5-Key Message
• Universal lipid screening in children is simple, effective, and can save lives.
• Detecting FH early means preventing early heart disease and protecting families across generations.
• The LEAD initiative aims to ensure no child is missed because of limited awareness or screening access.
